January 10, 2019
Rose
Sen. Chuck Grassley (R-Iowa) was one of a handful of lawmakers who have introduced legislation to curb high drug costs in the first few weeks of Congress being back in session. The topic is seen as one of only a few bipartisan issues that may get addressed by a divided Congress this year. In other pharmaceutical news, government officials are worried that drugmakers are using scare tactics to keep competition out of the marketplace.
from Kaiser Health News http://bit.ly/2SLoNYU
January 10, 2019
Rose
Health News, Kaiser Health News
No comments
Flurry Of Movement On Capitol Hill On Drug Pricing May Signal Possible Rough Waters Ahead For Pharma
Related Posts:
A National Registry Is Needed To Identify Babies Who Have Been Affected By Opioid Crisis, Lawyers Argue- Republicans May Be Stuck Between Rock And Hard Place On Voting For Democrats’ Drug Pricing Proposals
- First Edition: January 13, 2020
- ‘It Was Beautiful’ Once Upon A Time, Now LA Hospital Becomes Latest Casualty In Financially Uncertain Landscape
- Smokers Need Not Apply: Fairness Of No-Nicotine Hiring Policies Questioned
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment